Muir Peter, Schamberger Gwenn M, Manley Paul A, Hao Zhengling
Comparative Orthopaedic Research Laboratory, School of Veterinary Medicine, University of Wisconsin-Madison, 2015 Linden Drive, Madison, WI 53706, USA.
Vet Surg. 2005 May-Jun;34(3):239-46. doi: 10.1111/j.1532-950X.2005.00036.x.
To localize cathepsin K and tartrate-resistant acid phosphatase (TRAP) in synovium and cranial cruciate ligament (CCL) of dogs with cruciate disease.
Dogs (n=15) with cruciate disease and ruptured CCL, and 12 dogs with intact CCL.
Synovium and CCL were examined histologically and cells containing cathepsin K or TRAP were identified immunohistochemically and histochemically, respectively.
Increased cellular localization of cathepsin K and TRAP was detected in synovium and ruptured CCL in dogs with cruciate disease, when compared with tissues from dogs with intact CCL. Inflammation of synovium with TRAP+ macrophage-like cells was seen in 73% of dogs with CCL disease, but was not seen in dogs with intact CCL. The presence of cathepsin K and TRAP protein in synovium and CCL tissues was significantly correlated in dogs with CCL rupture.
Inflammation of the epiligament of ruptured CCL with cathepsin K+ and TRAP+ macrophage-like cells forms part of a similar, more generalized chronic inflammatory change within the periarticular tissues of the stifle of a large proportion of dogs with CCL rupture.
Production of matrix-degrading enzymes by the synovium may induce progressive pathologic rupture of the CCL. Therefore, these collagenolytic pathways may offer a novel target for medical therapy of joint inflammation in canine patients with cruciate disease.
在患有十字韧带疾病的犬的滑膜和颅交叉韧带(CCL)中定位组织蛋白酶K和抗酒石酸酸性磷酸酶(TRAP)。
15只患有十字韧带疾病且CCL断裂的犬,以及12只CCL完整的犬。
对滑膜和CCL进行组织学检查,并分别通过免疫组织化学和组织化学方法鉴定含有组织蛋白酶K或TRAP的细胞。
与CCL完整的犬的组织相比,在患有十字韧带疾病的犬的滑膜和断裂的CCL中检测到组织蛋白酶K和TRAP的细胞定位增加。在73%的CCL疾病犬中可见带有TRAP +巨噬细胞样细胞的滑膜炎,但在CCL完整的犬中未见。在CCL断裂的犬中,滑膜和CCL组织中组织蛋白酶K和TRAP蛋白的存在显著相关。
在大部分CCL断裂的犬的膝关节周围组织中,带有组织蛋白酶K +和TRAP +巨噬细胞样细胞的断裂CCL的韧带外层炎症是类似的、更普遍的慢性炎症变化的一部分。
滑膜产生的基质降解酶可能诱导CCL的进行性病理性断裂。因此,这些胶原溶解途径可能为患有十字韧带疾病的犬类患者的关节炎症医学治疗提供一个新的靶点。